These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27513379)

  • 1. Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.
    Xiridou M; Lugnér A; de Vries HJ; van Bergen JE; Götz HM; van Benthem BH; Wallinga J; van der Sande MA
    Sex Transm Dis; 2016 Sep; 43(9):542-8. PubMed ID: 27513379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.
    Harding-Esch EM; Huntington SE; Harvey MJ; Weston G; Broad CE; Adams EJ; Sadiq ST
    Euro Surveill; 2020 Oct; 25(43):. PubMed ID: 33124553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
    Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
    BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
    Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N
    BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
    Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
    Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Committee Opinion No. 645: Dual Therapy for Gonococcal Infections.
    Obstet Gynecol; 2016 May; 127(5):e95-9. PubMed ID: 27548425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
    Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
    Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline.
    Schumacher CM; Ghanem KG
    Sex Transm Dis; 2013 Jul; 40(7):539-45. PubMed ID: 23965767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis.
    Yin X; Li Y; Rönn MM; Li S; Yuan Y; Gift TL; Hsu K; Salomon JA; Grad YH; Yaesoubi R
    PLoS Med; 2024 Jul; 21(7):e1004424. PubMed ID: 38976754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
    Rice LB
    Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
    [No Abstract]   [Full Text] [Related]  

  • 16. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
    Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
    Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Committee Opinion No. 645 Summary: Dual Therapy for Gonococcal Infections.
    Obstet Gynecol; 2016 May; 127(5):1126. PubMed ID: 27548417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.